Drospas M 80 mg/250 mg Tablet
By Drospas M
Rx
10 Tablet in a Strip

Composition
Drotaverine(80mg) + Mefenamic Acid(250mg)

Manufacturer - Alchemist Life Science Ltd
Trilokpur Road, Sirmor, Kala Amb, Himachal Pradesh 134203

Expires on or after
October, 2025

liver
Drospas M 80 mg/250 mg Tablet needs to be used cautiously in individuals with liver disease. It may be necessary to adjust the dosage of this medication when taken by patients with liver issues. It is important to consult your doctor regarding the use of Drospas M 80 mg/250 mg Tablet if you have liver disease.

kidney
Drospas M 80 mg/250 mg Tablet should be used carefully in individuals with kidney problems. Adjustment of the dosage may be necessary. Avoid using in severe kidney disease. Please seek advice from your doctor.

alcohol
It is not safe to drink alcohol while taking Drospas M 80 mg/250 mg Tablet. Caution should be taken during pregnancy.

driving
Drospas M 80 mg/250 mg Tablet may cause side effects that could affect driving. Be cautious as it may lead to vertigo.

pregnancy
Drospas M 80 mg/250 mg Tablet may not be safe for use during pregnancy. Limited human studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before taking this medication.

breastfeeding
It is better to consult your doctor before using Drospas M 80 mg/250 mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹76
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024